Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.75 - $1.33 $103,431 - $183,417
-137,908 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.29 - $4.04 $4,877 - $15,275
3,781 Added 2.82%
137,908 $218,000
Q4 2021

Feb 14, 2022

SELL
$3.45 - $6.05 $127,198 - $223,057
-36,869 Reduced 21.56%
134,127 $440,000
Q3 2021

Nov 12, 2021

BUY
$5.53 - $9.28 $14,554 - $24,424
2,632 Added 1.56%
170,996 $1.06 Million
Q2 2021

Aug 16, 2021

BUY
$7.84 - $12.6 $270,613 - $434,914
34,517 Added 25.79%
168,364 $1.5 Million
Q1 2021

May 17, 2021

SELL
$10.54 - $19.3 $161,188 - $295,154
-15,293 Reduced 10.25%
133,847 $1.7 Million
Q4 2020

May 17, 2021

SELL
$12.79 - $17.1 $219,757 - $293,812
-17,182 Reduced 10.33%
149,140 $2.08 Million
Q4 2020

Feb 16, 2021

BUY
$12.79 - $17.1 $288,849 - $386,186
22,584 Added 15.71%
166,322 $2.32 Million
Q3 2020

Nov 16, 2020

BUY
$12.99 - $19.41 $22,394 - $33,462
1,724 Added 1.21%
143,738 $1.87 Million
Q2 2020

Aug 14, 2020

BUY
$12.19 - $22.96 $219 - $413
18 Added 0.01%
142,014 $2.48 Million
Q1 2020

May 14, 2020

BUY
$10.08 - $27.21 $8,951 - $24,162
888 Added 0.63%
141,996 $2.21 Million
Q4 2019

Feb 14, 2020

SELL
$13.05 - $21.88 $247,976 - $415,763
-19,002 Reduced 11.87%
141,108 $2.84 Million
Q3 2019

Nov 14, 2019

BUY
$14.12 - $23.44 $1.35 Million - $2.23 Million
95,308 Added 147.08%
160,110 $2.26 Million
Q2 2019

Aug 15, 2019

BUY
$13.21 - $27.29 $856,034 - $1.77 Million
64,802 New
64,802 $1.05 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.